Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 3,263 shares at $13.03 ($43K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Seasonal sale ($43k) by See Remarks — this insider has traded ARQT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |